ArticleBMC pregnancy and childbirth2025
Whole exome sequencing in fetal cardiac rhabdomyoma detected by ultrasonography: an analysis of 12 cases.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMost of fetal cardiac rhabdomyomas (CRs) are associated with tuberous sclerosis (TSC), an autosomal dominant inherited disorder caused by mutations in the TSC1 or TSC2 genes.
methodsIn this study, 12 fetuses with sonographically identified CR were included. A comprehensive analysis integrating prenatal echocardiographic findings, parental phenotypic characteristics, and genetic profiles of fetuses with CR were conducted. Karyotype and SNP-array/CNV-seq were performed simultaneously with Trio-WES.
resultsAll CRs were observed in the ventricle, interventricular septum, and the atrium, while the left ventricle were the most common areas. All subjects did not detect arrhythmia during pregnancy. Beside CRs, irregular low echo in the brain was detected in Case 12. TSC1 and TSC2 variants were identified in all 12 fetuses (100%). Mutants of TSC1 account for 25% (3/12) and TSC2 account for 75%(9/12). Two-thirds of these variants were de novo. The P/LP variant spectrums in TSC1/TSC2 includes 4 (34%) nonsense, 4 (33%) missense, 2 (17%) frameshift, 1 (8%) splice and 1 (8%) small deletion. A 780 kb deletion in 9q34.13 (arr[hg19] 9q34.13 (132286422-133062068) × 1) encompassing the entire of TSC1 gene, and the other two de novo mutants of c.1687G > C and c.1106delT in TSC2 gene had not been reported previously.
conclusionCombination of fetal CR detected by ultrasound and genetic testing can effectively diagnose the prenatal cases of TSC. Three novel variants in TSC genes enlarge the variants spectrum of TSC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.